Clinical Trial
The effect of fluphenazine upon social and vocational functioning in remitted schizophrenics
- PMID: 224958
Item in Clipboard
Clinical Trial
The effect of fluphenazine upon social and vocational functioning in remitted schizophrenics
Biol Psychiatry.
1979 Jun.
Abstract
Thirty-six remitted schizophrenics who participated in an outpatient study of fluphenazine decanoate or oral fluphenazine vs placebo given for a year were examined for the effect of drug treatment upon social and vocational functioning. Only the period prior to any clinical relapse was evaluated. We found no difference between those on drug or placebo, and conclude that antipsychotic drugs, at least in the context of an aftercare clinic offering a rich spectrum of nonpharmacological services, and when combined with antiparkinson medication, do not interfere with social and vocational functioning.
Similar articles
-
Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates.Int Clin Psychopharmacol. 1992 Nov;7(2):67-72. Int Clin Psychopharmacol. 1992. PMID: 1487623 Clinical Trial.
-
Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.J Clin Psychiatry. 1982 May;43(5):195-6. J Clin Psychiatry. 1982. PMID: 7076630
-
Comparison of fluphenazine decanoate, oral fluphenazine, and placebo in remitted outpatient schizophrenics.Psychopharmacol Bull. 1976 Apr;12(2):24-6. Psychopharmacol Bull. 1976. PMID: 769022 Clinical Trial. No abstract available.
-
The social value of fluphenazine decanoate.Acta Psychiatr Belg. 1976 Sep-Oct;76(5):792-804. Acta Psychiatr Belg. 1976. PMID: 799897 Review.
-
Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.J Psychiatry Neurosci. 1994 Jul;19(4):254-64. J Psychiatry Neurosci. 1994. PMID: 7918346 Free PMC article. Review.
Cited by
-
The effects of antipsychotic discontinuation or maintenance on the process of recovery in remitted first-episode psychosis patients - A systematic review and meta-analysis of randomized controlled trials.Eur Psychiatry. 2024 Jan 22;67(1):e13. doi: 10.1192/j.eurpsy.2024.5. Eur Psychiatry. 2024. PMID: 38250810 Free PMC article.
-
Maintenance treatment with antipsychotic drugs for schizophrenia.Cochrane Database Syst Rev. 2020 Aug 11;8(8):CD008016. doi: 10.1002/14651858.CD008016.pub3. Cochrane Database Syst Rev. 2020. PMID: 32840872 Free PMC article.
-
Use of the Social Behaviour Assessment Schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine.Soc Psychiatry. 1983;18(4):193-9. doi: 10.1007/BF00583530. Soc Psychiatry. 1983. PMID: 6356386 Clinical Trial. No abstract available.
-
Fluphenazine (oral) versus placebo for schizophrenia.Cochrane Database Syst Rev. 2013 Jul 17;7(7):CD006352. doi: 10.1002/14651858.CD006352.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2018 Jun 12;6:CD006352. doi: 10.1002/14651858.CD006352.pub3. PMID: 23861067 Free PMC article. Updated.
-
Fluphenazine decanoate (depot) and enanthate for schizophrenia.Cochrane Database Syst Rev. 2015 Feb 5;2015(2):CD000307. doi: 10.1002/14651858.CD000307.pub2. Cochrane Database Syst Rev. 2015. PMID: 25654768 Free PMC article.